The rating affirmation is based on a number of factors, including Halifax Health’s steady operating results and leading market share in its primary service area.
The outlook is stable.
Fitch has also affirmed Halifax Health’s following bonds:
- $115.1 million of series 2015 bonds at “BBB+”
- $42.7 million of series 2006A bonds at “BBB+”
- $107.9 million of series 2006B-1 and B-2 bonds at “BBB+”
- $70 million of series 2008 bonds at “BBB+”
More articles on healthcare finance:
RelayHealth financial reports 1.6% ICD-10 denial rate, MedAssets-Precyse launches new platform & more — 11 RCM key notes
California hospital to close after restructuring plan fails
From volume to value: The rules of the comprehensive joint replacement bundle
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
